A phase II study of depsipeptide [romidepsin] a histone descetylase inhibitor in relapsed or refractory mantle cell or diffuse large cell non-Hodgkin's lymphoma.
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2013
At a glance
- Drugs Romidepsin (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 Sep 2005 New trial record.